Anamnese brings quality to medical consultations. Our A.I. manages a clinical interrogation (ie reproducing a doctor's reasoning) to prepare a consultation before or ensure patient remission after.
Bodyo’s mission is to make health monitoring more freely available, in order to increase happiness, fitness, lower obesity levels and early detection of diabetes and chronic heart conditions to place our launch markets at the forefront for digital health.
To enable us to better do this, we have developed a unique set of tools to monitor health, preventing serious illnesses and provide data on usage, engagement and improvement. By mid 2018, the Bodyo AI Health Screening Stations will be less than 2.5km from key residential areas, with coverage in Dubai & Abu Dhabi to begin with.
Bodyo is the next generation results-based health and wellness monitoring and tracking platform, that connects, advises and monitors your life while you're on the go. We provide comprehensive and tailored health, nutrition, fitness and sleep solutions to inspire a wellness culture and strive towards a healthier lifestyle.
Calmedica sells interactive e-tools for medical follow up and care based on new communication technology. Based on a unique platform using artificial intelligence, our tools establish an automated conversation by sms. Our product Memoquest applied to the health sector and to the management of an ambulatory patient by a specialist doctor can collect patients'​ answers to targeted questions and trigger alerts by mail, if and only if, the patient gives an answer pre-defined as abnormal. Widely used in ambulatory surgery and after hospital discharge, it can be used in any situation where a follow up is necessary with an ambulatory patient. Our customers are hospitals and clinics looking for optimizing their ambulatory surgery unit or willing to reduce without risks the hospitalization duration. All the parameters are configurable according to the pathologies and clients'​ processes.
Sivan provides innovative digital therapeutic for the follow up of cancer patients. Thanks to its strong scientific evidence and clinical expertise, Sivan developed Moovcare®, the first application for early detection of relapses and complications in patients with lung cancer. Moovcare® is the first digital therapeutic officially reimbursed in France.